Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Meningococcal Vaccine bulk supplier for pharma manufacturers

Meningococcal Vaccine 0.5 mL Suppliers & Bulk Manufacturers

Available Forms: Vial or pre-filled syringe (injectable), Conjugate vaccines

Available Strengths: 0.5 mL

Reference Brands: Menactra, Menveo(US), NmVac4-DT (India)

Category: Vaccines

Meningococcal vaccines stimulate immunity by introducing purified polysaccharide or protein antigens from Neisseria meningitidis bacteria. They produce protective antibodies, preventing meningococcal meningitis and septicemia. Benefits include long-lasting immunity, outbreak control, and protection for high-risk populations, supporting global efforts to reduce meningococcal disease morbidity and mortality.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Meningococcal vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and IVDR standards. In the US, FDA approval involves extensive clinical data, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and quality audits, with comprehensive documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective meningococcal vaccines vital for disease prevention, outbreak control, and protection of high-risk populations globally.

Meningococcal Vaccine — third party manufacturing & bulk supply

Meningococcal Vaccine 0.5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Meningococcal Vaccine is supplied as Vial or pre-filled syringe (injectable), Conjugate vaccines — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Meningococcal Vaccine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Meningococcal Vaccine →
Back to Listing

Frequently Asked Questions

Meningococcal Vaccine is used to prevent meningococcal disease caused by the bacterium Neisseria meningitidis. This serious infection can lead to meningitis (infection of the lining of the brain and spinal cord) and bloodstream infections. The vaccine helps protect individuals, especially children, adolescents, and travelers to high-risk regions.

Meningococcal vaccines are made from purified components of the Neisseria meningitidis bacteria. Depending on the type, they may contain polysaccharides from the bacterial capsule or conjugated polysaccharides linked to a carrier protein to enhance immune response.

Common trade names include Menactra, Menveo, Nimenrix, Bexsero, and Trumenba.

Meningococcal vaccines are manufactured by several pharmaceutical companies including Sanofi Pasteur, GlaxoSmithKline (GSK), Pfizer, and Serum Institute of India.

The generic name is meningococcal vaccine or meningococcal conjugate vaccine depending on the formulation.

Brand names include Menactra, Menveo, Nimenrix, Bexsero, and Trumenba.

Meningococcal vaccines are manufactured in multiple countries including the United States, United Kingdom, Italy, Belgium, and India depending on the manufacturer.

Related Products

Cholera Vaccine

Strength:
2.0 mL

Form: Oral live attenuated vaccine (liquid suspension), Inactivated killed vaccine (injectable)

Reference Brands: Dukoral(USA), Shanchol(India/EU)

View Details
Mrna-Based Vaccines

Strength:
30 µg and 100 µg

Form: Injectable suspension

Reference Brands: Comirnaty, Spikevax(US)

View Details
Japanese Encephalitis Vaccine

Strength:
0.5 mL

Form: Lyophilized powder, Pre-filled syringes

Reference Brands: IXIARO(US)

View Details
Viral Vector Vaccines

Strength:
0.5 mL

Form: Intramuscular injectable suspension (IM)

Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)

View Details
Pneumococcal Vaccine

Strength:
23MG

Form: Injection

Reference Brands:

View Details
Haemophilus Type B Conjugate Vaccine

Strength:
10 mcg+ 25mcg, 7.5 mcg + 125 mcg

Form: Injection

Reference Brands: ActHIB (USA), Hiberix (USA), EasyFive-TT (India)

View Details
Yellow Fever Vaccine

Strength:
-

Form: Injection

Reference Brands:

View Details
Docaravimab, Miromavimab

Strength:
600IU

Form: Injection

Reference Brands: TWINRAB

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.